West Pharmaceutical Services, Inc. (WST)
367.74
+1.74
(+0.48%)
USD |
NYSE |
Oct 12, 16:00
368.20
+0.46
(+0.12%)
After-Hours: 18:06
West Pharmaceutical Services Free Cash Flow (Quarterly) : 80.80M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 80.80M |
| March 31, 2026 | 47.20M |
| December 31, 2025 | 175.00M |
| September 30, 2025 | 133.90M |
| June 30, 2025 | 101.90M |
| March 31, 2025 | 58.10M |
| December 31, 2024 | 85.20M |
| September 30, 2024 | 98.80M |
| June 30, 2024 | 64.80M |
| March 31, 2024 | 27.60M |
| December 31, 2023 | 130.40M |
| September 30, 2023 | 134.30M |
| June 30, 2023 | 93.80M |
| March 31, 2023 | 56.00M |
| December 31, 2022 | 135.90M |
| September 30, 2022 | 111.10M |
| June 30, 2022 | 107.00M |
| March 31, 2022 | 85.40M |
| December 31, 2021 | 84.30M |
| September 30, 2021 | 124.80M |
| June 30, 2021 | 87.50M |
| March 31, 2021 | 34.00M |
| December 31, 2020 | 94.80M |
| September 30, 2020 | 71.10M |
| June 30, 2020 | 107.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 25.00M |
| December 31, 2019 | 68.80M |
| September 30, 2019 | 76.40M |
| June 30, 2019 | 76.80M |
| March 31, 2019 | 18.80M |
| December 31, 2018 | 43.20M |
| September 30, 2018 | 61.90M |
| June 30, 2018 | 61.80M |
| March 31, 2018 | 17.00M |
| December 31, 2017 | 52.00M |
| September 30, 2017 | 41.50M |
| June 30, 2017 | 55.80M |
| March 31, 2017 | -16.80M |
| December 31, 2016 | 24.30M |
| September 30, 2016 | 19.70M |
| June 30, 2016 | 41.20M |
| March 31, 2016 | -36.00M |
| December 31, 2015 | 23.20M |
| September 30, 2015 | 39.10M |
| June 30, 2015 | 50.80M |
| March 31, 2015 | -32.30M |
| December 31, 2014 | 18.90M |
| September 30, 2014 | 35.30M |
| June 30, 2014 | 39.70M |
| March 31, 2014 | -22.90M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Globus Medical, Inc. | 176.57M |
| Hinge Health, Inc. | 99.56M |
| The Cooper Cos., Inc. | 273.00M |
| Becton, Dickinson & Co. | 509.00M |
| Thermo Fisher Scientific, Inc. | 1.675B |